1085 related articles for article (PubMed ID: 18000388)
21. SNP analysis of minimally evolved t(14;18)(q32;q21)-positive follicular lymphomas reveals a common copy-neutral loss of heterozygosity pattern.
Cheung KJ; Rogic S; Ben-Neriah S; Boyle M; Connors JM; Gascoyne RD; Horsman DE
Cytogenet Genome Res; 2012; 136(1):38-43. PubMed ID: 22104078
[TBL] [Abstract][Full Text] [Related]
22. Multiple recurrent chromosomal breakpoints in mantle cell lymphoma revealed by a combination of molecular cytogenetic techniques.
Salaverria I; Espinet B; Carrió A; Costa D; Astier L; Slotta-Huspenina J; Quintanilla-Martinez L; Fend F; Solé F; Colomer D; Serrano S; Miró R; Beà S; Campo E
Genes Chromosomes Cancer; 2008 Dec; 47(12):1086-97. PubMed ID: 18709664
[TBL] [Abstract][Full Text] [Related]
23. Rearrangements of chromosome band 1p36 in non-Hodgkin's lymphoma.
Dave BJ; Hess MM; Pickering DL; Zaleski DH; Pfeifer AL; Weisenburger DD; Armitage JO; Sanger WG
Clin Cancer Res; 1999 Jun; 5(6):1401-9. PubMed ID: 10389925
[TBL] [Abstract][Full Text] [Related]
24. Combined spectral karyotyping and DAPI banding analysis of chromosome abnormalities in myelodysplastic syndrome.
Kakazu N; Taniwaki M; Horiike S; Nishida K; Tatekawa T; Nagai M; Takahashi T; Akaogi T; Inazawa J; Ohki M; Abe T
Genes Chromosomes Cancer; 1999 Dec; 26(4):336-45. PubMed ID: 10534769
[TBL] [Abstract][Full Text] [Related]
25. MALT lymphoma with t(14;18)(q32;q21)/IGH-MALT1 is characterized by strong cytoplasmic MALT1 and BCL10 expression.
Ye H; Gong L; Liu H; Hamoudi RA; Shirali S; Ho L; Chott A; Streubel B; Siebert R; Gesk S; Martin-Subero JI; Radford JA; Banerjee S; Nicholson AG; Ranaldi R; Remstein ED; Gao Z; Zheng J; Isaacson PG; Dogan A; Du MQ
J Pathol; 2005 Feb; 205(3):293-301. PubMed ID: 15682443
[TBL] [Abstract][Full Text] [Related]
26. Recurrent chromosomal abnormalities in lymphomas in fine needle aspirates of lymph node.
Trcić RL; Sustercić D; Kuspilić M; Jelić-Puskarić B; Fabijanić I; Kardum-Skelin I
Coll Antropol; 2010 Jun; 34(2):387-93. PubMed ID: 20698107
[TBL] [Abstract][Full Text] [Related]
27. Acquisition of a t(11;14)(q13;q32) in clonal evolution in a follicular lymphoma with a t(14;18)(q32;q21) and t(3;22)(q27;q11.2).
Koduru PR; Chen W; Garcia R; Fuda F
Cancer Genet; 2015 Jun; 208(6):303-9. PubMed ID: 25953460
[TBL] [Abstract][Full Text] [Related]
28. Primary cutaneous marginal zone B-cell lymphoma may exhibit both the t(14;18)(q32;q21) IGH/BCL2 and the t(14;18)(q32;q21) IGH/MALT1 translocation: an indicator for clonal transformation towards higher-grade B-cell lymphoma?
Palmedo G; Hantschke M; Rütten A; Mentzel T; Kempf W; Tomasini D; Kutzner H
Am J Dermatopathol; 2007 Jun; 29(3):231-6. PubMed ID: 17519619
[TBL] [Abstract][Full Text] [Related]
29. Combined molecular diagnosis of B-cell lymphomas with t(11;14)(q13;q32) or t(14;18)(q32;q21) using multiplex- and long distance inverse-polymerase chain reaction.
Vieira L; Martinho A; Antunes O; Silva E; Ambrósio AP; Geraldes MC; Nascimento R; Silva C; Pereira JM; Júnior EC; Jordan P
Diagn Mol Pathol; 2008 Jun; 17(2):73-81. PubMed ID: 18382373
[TBL] [Abstract][Full Text] [Related]
30. Variant t(14;18) in malignant lymphoma: a report of seven cases.
Bentley G; Palutke M; Mohamed AN
Cancer Genet Cytogenet; 2005 Feb; 157(1):12-7. PubMed ID: 15676141
[TBL] [Abstract][Full Text] [Related]
31. Spectral karyotyping identifies new rearrangements, translocations, and clinical associations in diffuse large B-cell lymphoma.
Nanjangud G; Rao PH; Hegde A; Teruya-Feldstein J; Donnelly G; Qin J; Jhanwar SC; Zelenetz AD; Chaganti RS
Blood; 2002 Apr; 99(7):2554-61. PubMed ID: 11895793
[TBL] [Abstract][Full Text] [Related]
32. Identification of new translocations involving ETV6 in hematologic malignancies by fluorescence in situ hybridization and spectral karyotyping.
Odero MD; Carlson K; Calasanz MJ; Lahortiga I; Chinwalla V; Rowley JD
Genes Chromosomes Cancer; 2001 Jun; 31(2):134-42. PubMed ID: 11319801
[TBL] [Abstract][Full Text] [Related]
33. Multicolour fluorescence in situ hybridization analysis of t(14;18)-positive follicular lymphoma and correlation with gene expression data and clinical outcome.
Lestou VS; Gascoyne RD; Sehn L; Ludkovski O; Chhanabhai M; Klasa RJ; Husson H; Freedman AS; Connors JM; Horsman DE
Br J Haematol; 2003 Sep; 122(5):745-59. PubMed ID: 12930384
[TBL] [Abstract][Full Text] [Related]
34. Characterization of IGH rearrangements in non-Hodgkin's B-cell lymphomas by fluorescence in situ hybridization.
Bernicot I; Douet-Guilbert N; Le Bris MJ; Morice P; Abgrall JF; Berthou C; Morel F; De Braekeleer M
Anticancer Res; 2005; 25(5):3179-82. PubMed ID: 16101124
[TBL] [Abstract][Full Text] [Related]
35. Serial cytogenetic alterations resulting in transformation of a low-grade follicular lymphoma to Burkitt lymphoma.
Li L; Gupta S; Bashir T; Koduru PR; Brody J; Allen SL
Cancer Genet Cytogenet; 2006 Oct; 170(2):140-6. PubMed ID: 17011985
[TBL] [Abstract][Full Text] [Related]
36. Chromosomal aberrations in follicular non-Hodgkin lymphomas of Japanese patients, detected with comparative genomic hybridization and polymerase chain reaction analysis.
D'Haese JG; Tsukasaki K; Cremer FW; Fischer C; Bartram CR; Jauch A
Cancer Genet Cytogenet; 2005 Oct; 162(2):107-14. PubMed ID: 16213357
[TBL] [Abstract][Full Text] [Related]
37. New chromosome abnormalities and lack of BCL-6 gene rearrangements in Argentinean diffuse large B-cell lymphomas.
Cerretini R; Noriega MF; Narbaitz M; Slavutsky I
Eur J Haematol; 2006 Apr; 76(4):284-93. PubMed ID: 16519699
[TBL] [Abstract][Full Text] [Related]
38. Primary effusion lymphoma of the pericardial cavity carrying t(1;22)(q21;q11) and t(14;17)(q32;q23).
Fujiwara T; Ichinohasama R; Miura I; Sugawara T; Harigae H; Yokoyama H; Takahashi S; Tomiya Y; Yamada M; Ishizawa K; Kameoka J; Sasaki T
Cancer Genet Cytogenet; 2005 Jan; 156(1):49-53. PubMed ID: 15588855
[TBL] [Abstract][Full Text] [Related]
39. Combined spectral karyotyping, comparative genomic hybridization, and in vitro apoptyping of a panel of Burkitt's lymphoma-derived B cell lines reveals an unexpected complexity of chromosomal aberrations and a recurrence of specific abnormalities in chemoresistant cell lines.
Karpova MB; Schoumans J; Blennow E; Ernberg I; Henter JI; Smirnov AF; Nordenskjöld M; Fadeel B
Int J Oncol; 2006 Mar; 28(3):605-17. PubMed ID: 16465364
[TBL] [Abstract][Full Text] [Related]
40. G-banding and molecular cytogenetic analyses of marginal zone lymphoma.
Aamot HV; Micci F; Holte H; Delabie J; Heim S
Br J Haematol; 2005 Sep; 130(6):890-901. PubMed ID: 16156859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
